Tower Research Capital LLC (Trc) Kala Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.07 Billion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.25 - $0.36 $9,764 - $14,060	39,058 New	39,058 $9,000
Q2 2022 Aug 15, 2022	SELL	$0.3 - $1.31 $3,474 - $15,169	-11,580 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.61 - $1.84 $15,982 - $48,209	-26,201 Reduced 69.35%	11,580 $16,000
Q4 2021 Feb 14, 2022	BUY	$1.16 - $2.74 $39,775 - $93,951	34,289 Added 981.93%	37,781 $46,000
Q3 2021 Nov 15, 2021	SELL	$2.62 - $5.43 $15,193 - $31,488	-5,799 Reduced 62.42%	3,492 $9,000

Q2 2021 Aug 16, 2021	BUY	$5.06 - $8.15 $28,199 - $45,419	5,573 Added 149.89%	9,291 $49,000
Q1 2021 May 17, 2021	SELL	$6.24 - $9.58 $68,128 - $104,594	-10,918 Reduced 74.6%	3,718 $25,000
Q4 2020 Feb 16, 2021	SELL	$6.28 - $8.79 $163,562 - $228,935	-26,045 Reduced 64.02%	14,636 $99,000
Q3 2020 Nov 16, 2020	BUY	$7.5 - $11.11 $266,445 - $394,693	35,526 Added 689.16%	40,681 $305,000
Q2 2020 Aug 13, 2020	BUY	$8.33 - $13.79 $42,941 - $71,087	5,155 New	5,155 $54,000
Q1 2020 May 15, 2020	SELL	$3.83 - $8.79 $46,461 - $106,631	-12,131 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$3.36 - $4.81 $26,990 - $38,638	8,033 Added 196.02%	12,131 $45,000
Q3 2019 Nov 05, 2019	BUY	$3.57 - $6.58 $14,629 - $26,964	4,098 New	4,098 $16,000
Q2 2019 Aug 13, 2019	SELL	$4.93 - $8.8 $2,548 - $4,549	-517 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$5.19 - $8.97 $11,355 - $19,626	-2,188 Reduced 80.89%	517 $4,000
Q4 2018 Feb 14, 2019	BUY	$4.29 - $9.94 $11,604 - $26,887	2,705 New	2,705 $14,000
Q3 2018 Nov 13, 2018	SELL	$9.54 - $13.87 $2,757 - $4,008	-289 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$13.3 - $17.49 $3,843 - $5,054	289 New	289 $4,000
Q1 2018 May 15, 2018	SELL	$12.26 - $18.98 $13,866 - $21,466	-1,131 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$13.68 - $23.17 $6,785 - $11,492	496 Added 78.11%	1,131 $21,000
Q3 2017 Nov 14, 2017	BUY	$19.86 - $26.53 $12,611 - $16,846	635	635 $15,000

Others Institutions Holding KALA

# of Institutions

Shares Held

Call Options Held

Put Options Held

Parallel Advisors, LLC

1
Shares

$7
0.0% of portfolio

View Full List

About Kala Pharmaceuticals, Inc.

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.4M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

More about KALA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account